Interleukin-4 Receptor alpha Antagonist [EPC] - N0000193342
Pharmacologic Class Information
Pharmacologic Code | N0000193342 |
Pharmacologic Name | Interleukin-4 Receptor alpha Antagonist |
Pharmacologic Uses |
|
Pharmacologic Concept | Established Pharmacologic Classes - [EPC] |
Pharmacologic Concept Description | An established pharmacologic class is a term or phrase that is scientifically valid
and clinically meaningful according to the following definitions:
|
NDC Products with Interleukin-4 Receptor alpha Antagonist
The table contains 5 products whose active ingredient are classified under the same pharmacologic class Interleukin-4 Receptor alpha Antagonist [EPC].
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
---|---|---|---|---|---|---|---|
0024-5911 | Dupixent | Non-Proprietary Name: Dupilumab | Injection, Solution | Subcutaneous | Sanofi-aventis U.s. Llc | ACTIVE | |
0024-5914 | Dupixent | Non-Proprietary Name: Dupilumab | Injection, Solution | Subcutaneous | Sanofi-aventis U.s. Llc | ACTIVE | |
0024-5915 | Dupixent | Non-Proprietary Name: Dupilumab | Injection, Solution | Subcutaneous | Sanofi-aventis U.s. Llc | ACTIVE | |
0024-5918 | Dupixent | Non-Proprietary Name: Dupilumab | Injection, Solution | Subcutaneous | Sanofi-aventis U.s. Llc | ACTIVE | |
0024-5919 | Dupixent | Non-Proprietary Name: Dupilumab | Injection, Solution | Subcutaneous | Sanofi-aventis U.s. Llc | ACTIVE |